Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335945 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
A Phase 1 study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01335945 is a Phase 1 study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 14 participants.
The verdict
NCT01335945, a Phase 1 study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
CUC10-PAN09 will evaluate the safety and efficacy of cryoablation therapy on the relief of epigastric/abdominal pain associated with pancreatic cancer.
Interventions
- PROCEDURE Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2011-08 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01335945
The ClinicalTrials.gov registry entry for NCT01335945 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cryoablation is the first listed.
NCT01335945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01335945 about?
NCT01335945 is a clinical study titled "Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer". CUC10-PAN09 will evaluate the safety and efficacy of cryoablation therapy on the relief of epigastric/abdominal pain associated with pancreatic cancer.
What is the current status of trial NCT01335945?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2011-08. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01335945?
The interventions under investigation include: Cryoablation (PROCEDURE).
Who is sponsoring clinical trial NCT01335945?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.